Interpace Biosciences, Inc. Share Price
Stocks
IDXGD
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
19:08:30 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.980 USD | -0.29% |
|
-3.72% | +13.48% |
| Market Cap | 38.67M 33.36M 31.43M 28.63M 53.52M 3.65B 53.92M 372M 144M 1.87B 145M 142M 6.14B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 37.35M 32.22M 30.35M 27.65M 51.69M 3.53B 52.08M 359M 139M 1.8B 140M 137M 5.93B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.29% | ||
| 1 week | -3.72% | ||
| Current month | -7.79% | ||
| 1 month | -7.98% | ||
| 3 months | -20.68% | ||
| 6 months | -22.87% | ||
| Current year | +13.48% |
| 1 week | 6.5 |  | 7.8 |
| 1 month | 6.5 | | 8.5 |
| Current year | 5.15 | | 12 |
| 1 year | 3.85 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 51.65 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 30/11/2020 |
| Director of Finance/CFO | 34 | 20/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 20/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 31/12/2015 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 21/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Free | Director | 69,252 | 0.2501% | ||
| 20/08/26 | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 20/08/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | -3.72% | +64.24% | +32.95% | 38.78M | |
| +1.37% | -3.93% | +92.02% | +420.10% | 46.24B | |
| +1.24% | -1.21% | +21.14% | +60.55% | 26.57B | |
| +0.91% | -5.97% | -16.89% | -41.16% | 6.94B | |
| +0.24% | -1.01% | +7.67% | +132.42% | 5.94B | |
| +0.61% | -1.09% | +18.71% | +74.09% | 3.35B | |
| +2.25% | -3.95% | -32.35% | +1,829.25% | 2.53B | |
| -0.29% | +0.17% | +97.50% | +14.70% | 2.24B | |
| +5.30% | +5.41% | +29.15% | +33.54% | 2.03B | |
| -2.60% | -5.64% | -13.69% | -55.31% | 1.88B | |
| Average | +0.87% | -1.63% | +26.75% | +250.11% | 9.78B | |
| Weighted average by Cap. | +1.20% | -3.45% | +50.94% | +270.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.48M 38.14M 34.75M 64.95M 4.43B 65.43M 451M 175M 2.27B 176M 172M 7.44B | 38.73M 33.41M 31.47M 28.68M 53.6M 3.66B 54M 373M 145M 1.87B 145M 142M 6.14B |
| Net income | 6.7M 5.78M 5.45M 4.96M 9.28M 633M 9.35M 64.48M 25.03M 324M 25.17M 24.62M 1.06B | 24.58M 21.2M 19.97M 18.2M 34.01M 2.32B 34.27M 236M 91.76M 1.19B 92.28M 90.26M 3.9B |
| Net Debt | 4.4M 3.79M 3.57M 3.25M 6.08M 415M 6.13M 42.29M 16.41M 212M 16.5M 16.14M 697M | -1.32M -1.14M -1.07M -979K -1.83M -125M -1.84M -12.72M -4.94M -63.85M -4.96M -4.86M -210M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | US$6.980 | -0.29% | 5,330 |
| 01/09/26 | US$7.000 | -7.53% | 23,836 |
| 31/08/26 | US$7.570 | -0.63% | 5,519 |
| 28/08/26 | US$7.618 | +5.08% | 2,520 |
| 26/08/26 | US$7.250 | +2.11% | 1,420 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXGD Stock
Select your edition
All financial news and data tailored to specific country editions
